Electra Therapeutics Inc. ETRA · SEC Filings

website

Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies aga...

Price8.22

Market Cap515.94 M

Float23.33 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

8-K

Electra Therapeutics, Inc. Closes Initial Public Offering and Adopts Amended Corporate Governance Documents

Sep 21, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B4

Form 424B4 - Prospectus [Rule 424(b)(4)]

Sep 18, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 21, 2026

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Sep 18, 2026

S-1MEF

OFFERING

Sep 17, 2026

S-1/A

OFFERING - IPO

Sep 14, 2026

S-1

Form S-1 - General form for registration of securities under the Securities Act of 1933

Aug 28, 2026

DRS/A

Form DRS/A - Draft Registration Statement: [Amend]

Aug 10, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

GORDON CARL L (Reporting)

Nov 5, 2026

ORBIMED ADVISORS LLC (Reporting)

Nov 5, 2026

SCHEDULE 13G

Westlake BioPartners Fund I, L.P. (Filed by)

Oct 29, 2026

SCHEDULE 13G

Redmile Group, LLC (Filed by)

Sep 28, 2026

SCHEDULE 13G

LSP 7 Cooperatief U.A. (Filed by)

Sep 28, 2026

SCHEDULE 13D

ORBIMED ADVISORS LLC (Filed by)

Sep 25, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 18, 2026